Information:
Error:
ID
19516
Description
Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT00289367
Link
https://clinicaltrials.gov/show/NCT00289367
Keywords
Versions (1)
- 1/6/17 1/6/17 -
Uploaded on
January 6, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Atrial Fibrillation NCT00289367
Eligibility Atrial Fibrillation NCT00289367
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT00289367
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Coronary Artery Bypass Surgery Patient need for | Repair of heart valve Patient need for | Heart valve replacement Patient need for
Item
1. patients requiring cabg or valve repair/replacement surgery.
boolean
C0010055 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0190112 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
C0190173 (UMLS CUI [3,1])
C0686904 (UMLS CUI [3,2])
C0686904 (UMLS CUI [1,2])
C0190112 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
C0190173 (UMLS CUI [3,1])
C0686904 (UMLS CUI [3,2])
Informed Consent
Item
2. patient must be able to provide informed consent.
boolean
C0021430 (UMLS CUI [1])
Age
Item
1. patients less than 18 or over 85 years of age.
boolean
C0001779 (UMLS CUI [1])
Body Weight
Item
2. patients less than 50kg or greater than 120kg.
boolean
C0005910 (UMLS CUI [1])
Endocrine System Diseases | Diabetes Mellitus
Item
3. patients currently with endocrine disorders, excluding diabetes.
boolean
C0014130 (UMLS CUI [1])
C0011849 (UMLS CUI [2])
C0011849 (UMLS CUI [2])
Thyroid dysfunction | Thyroid dysfunction Treated | Hyperthyroidism | Goiter | Graves Disease | Myxedema | Myxedema coma
Item
4. patients currently with thyroid dysfunction (e.g., hyper- hyperthyroidism, goiter, grave's disease), myxedema, or myxedema coma, even if treated.
boolean
C0348024 (UMLS CUI [1])
C0348024 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0020550 (UMLS CUI [3])
C0018021 (UMLS CUI [4])
C0018213 (UMLS CUI [5])
C0027145 (UMLS CUI [6])
C0238298 (UMLS CUI [7])
C0348024 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0020550 (UMLS CUI [3])
C0018021 (UMLS CUI [4])
C0018213 (UMLS CUI [5])
C0027145 (UMLS CUI [6])
C0238298 (UMLS CUI [7])
Thyroid hormone replacement therapy
Item
5. patients currently receiving thyroid replacement therapy.
boolean
C2242640 (UMLS CUI [1])
Ketamine | Norepinephrine | Dietary iodine intake Supplementation
Item
6. patients currently receiving ketamine, levarterenol or dietary (non-food) iodine supplementation.
boolean
C0022614 (UMLS CUI [1])
C0028351 (UMLS CUI [2])
C3840145 (UMLS CUI [3,1])
C0242297 (UMLS CUI [3,2])
C0028351 (UMLS CUI [2])
C3840145 (UMLS CUI [3,1])
C0242297 (UMLS CUI [3,2])
Investigational New Drugs
Item
7. patients who have received any investigational drugs within the previous one month or five half-lives of the drug.
boolean
C0013230 (UMLS CUI [1])
Pregnancy | Childbearing Potential Pregnancy Test
Item
8. patients who are pregnant. pregnancy testing will be done for women of child-bearing potential.
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0032976 (UMLS CUI [2,2])
C3831118 (UMLS CUI [2,1])
C0032976 (UMLS CUI [2,2])
Atrial Fibrillation
Item
9. patients currently in atrial fibrillation.
boolean
C0004238 (UMLS CUI [1])